Eric Humphriss

A Randomized Safety and Efficacy Study of Somavaratan (VRS-317), a Long-Acting rhGH, in Pediatric Growth Hormone Deficiency

Wayne V. Moore, Huong Jil Nguyen, Gad B. Kletter et al. · The Journal of Clinical Endocrinology & Metabolism · 2015 · 48 citations · Full text

A Long-Acting Human Growth Hormone With Delayed Clearance (VRS-317): Results of a Double-Blind, Placebo-Controlled, Single Ascending Dose Study in Growth Hormone–Deficient Adults

Kevin C.J. Yuen, Gerard S. Conway, Vera Popović et al. · The Journal of Clinical Endocrinology & Metabolism · 2013 · 46 citations · Full text

Safety and Efficacy of Subcutaneous-Administered Omacetaxine Mepesuccinate in Imatinib-Resistant Chronic Myeloid Leukemia (CML) Patients Who Harbor the Bcr- Abl T315I Mutation–Results of An Ongoing Multicenter Phase 2/3 Study.

Jörge E. Cortes, H. Jean Khoury, Franck E. Nicolini et al. · Blood · 2009 · 40 citations

Safety and Efficacy of Subcutaneous-Administered Omacetaxine Mepesuccinate in Chronic Myeloid Leukemia (CML) Patients Who Are Resistant or Intolerant to Two or More Tyrosine Kinase Inhibitors – Results of A Multicenter Phase 2/3 Study.

Jörge E. Cortes, Raghunadharao Digumarti, Purvish Parikh et al. · Blood · 2009 · 32 citations

Safety and Efficacy of Subcutaneous (SC) Omacetaxine Mepesuccinate in Imatinib(IM)-Resistant Chronic Myeloid Leukemia (CML) Patients (pts) with the T315I Mutation – Results of An Ongoing Multicenter Phase II Study.

Jörge E. Cortes, H. Jean Khoury, Sélim Corm et al. · Blood · 2008 · 15 citations